D
iarrheal illness and dehydration are among the main causes of childhood fatality around the world. Even in the United States, gastroenteritis produces significant morbidity and mortality, resulting in more than 300 pediatric deaths and 200,000 hospitalizations each year, 1 with total yearly medical costs exceeding $2 billion. 2 Multiple guidelines recommend the use of oral rehydration therapy (ORT) for the treatment of mild to moderate dehydration. [1] [2] [3] Previous studies have shown reductions in hospital admission rates and emergency department (ED) length of stay, as well as improved patient satisfaction with ORT in comparison with intravenous fluid (IVF) therapy. 4, 5 Guidelines also exist recommending that patients with mild to moderate dehydration should not generally receive laboratory tests. 1, 6 While many developing countries follow these guidelines, developed countries, including the United States, rely heavily on the use of intravenous rehydration and frequently obtain laboratory studies for even mild cases of dehydration. [7] [8] [9] In addition to guidelines and literature supporting the use of ORT over IVF, several randomized controlled trials have shown that the oral antiemetic ondansetron decreases vomiting, decreases hospital admissions, and improves success rates of ORT in children in the emergency room setting without significant adverse effects. 10, 11 There is growing consensus in the scientific literature that ondansetron is a safe and effective addition to the ED management of gastroenteritis, but its use varies widely. In 1 US study, one-third of physicians stated they did not use antiemetics routinely in vomiting children. 7 In a recent study in Canadian EDs, use of antiemetics for children with gastroenteritis varied from 0% to 38% by hospital site. 12 Studies have shown the utility of protocols to allow nurseinitiated care starting at the time of triage for a variety of conditions, [13] [14] [15] [16] [17] including favorable results from the early use of ORT, initiated after triage and before physician assessment. [18] [19] [20] A recent study found that 16% of EDs in Ontario, Canada, reported having directives in place allowing nurse-initiated administration of antiemetics, 21 but no currently published clinical studies specifically address the effects of ondansetron administration by nursing staff at the time of triage.
The purpose of this study was to assess the effects of implementation of a protocol allowing initiation of antiemetic therapy and ORT for pediatric gastroenteritis patients at the time of ED triage, based on a formal assessment of dehydration by the triage nurse.
METHODS

Study Design and Setting
This study was a preintervention and postintervention analysis of the use of a clinical pathway to support the initiation of gastroenteritis assessment and management in triage. It was conducted in the ED of an urban, tertiary-care, pediatric teaching hospital with an annual pediatric ED census of approximately 11,000 children. The relevant institutional review board approved the study prior to protocol implementation and data collection.
Patient Selection
Patients were eligible for inclusion if they were between 6 months and 5 years of age and presented to the ED with concern for gastroenteritis, specifically defined here as diarrhea with or without vomiting. Prospective enrollment of postintervention patients began on the protocol implementation date of November 8, 2011, and continued through April 30, 2012.
Nurses were encouraged to enroll all eligible patients, but missed eligible cases were not analyzed. Patients were excluded if they had a relevant chronic disease (eg, active oncologic process, cystic fibrosis, metabolic disease). Children with chronic diseases that were considered unlikely to have a significant impact on the treatment of gastroenteritis and dehydration, such as asthma or epilepsy, were not excluded. To avoid offering oral rehydration to potential surgical patients, those with vomiting without diarrhea or with severe abdominal pain were excluded.
Control subjects were selected based on retrospective review of medical records from the 4 months prior to implementation for patients with chief complaints consistent with gastroenteritis. Patients were eligible for inclusion as control subjects if they reported a history of diarrhea with or without vomiting at the time of triage, indicating that they would have been candidates for treatment under the protocol had it been implemented. To match the approach used in the postintervention period, patients who mentioned abdominal pain in their chief complaint were included unless there was evidence this pain was reported as severe at the time of triage. Chronically ill patients were excluded under the same criteria used for patients in the postimplementation group.
Intervention
The pathway (Fig. 1 ) was developed by a team of ED nurses and physicians. It consisted of an algorithm outlining an approach to the patient with concern for dehydration due to gastroenteritis. Care began at triage with nurse assessment of the degree of dehydration using a standardized scale (Table 1) , adapted from Bailey *Point values are added up to obtain a final score. Zero indicates "no dehydration"; 1 to 4 indicates "some dehydration," and 5 to 8 indicates "moderate to severe dehydration." et al. 22 The pathway was introduced to nurses and physicians in formal and informal meetings conducted by the investigators prior to the implementation date. If a patient was determined to have "some" dehydration according to the scale (scores 1-4), formal ORT with measured amounts of solution to be given at scheduled time intervals was to begin immediately. World Health Organization oral rehydration solution (WHO ORS) packets were made available for this purpose, although alternative solutions (eg, sports drinks, breast milk, commercially available infant rehydration solutions) could be substituted at clinician or family discretion. Children who were determined to have "no" dehydration according to the scale (score 0) were to be offered an unstructured oral challenge of water, milk, juice, an ice pop, or the rehydration solution. It was found that neither the WHO ORS nor the scheduled administration of small, intermittent volumes of oral fluid was well tolerated in mildly dehydrated patients, as they and their families preferred unstructured administration of more palatable fluids. Two months into the study period, the study materials were modified to recommend an unstructured oral challenge with the fluid of the child's or family's choice for all patients with dehydration score of 0 or 1, reserving structured oral rehydration for patients with scores of 2 to 4.
If a child had recent or active vomiting according to the judgment of the triage nurse, an antiemetic (ondansetron orally dissolving tablet or liquid) was administered prior to the initiation of oral rehydration or the oral challenge. This usage of ondansetron in children is off-label but is well supported by the pediatric literature as noted previously. To facilitate prompt physician assessment of children who were more ill, patients determined to have "moderate or severe" dehydration (scores 5-8) were not eligible for the triage-based pathway; they were to be brought to the attention of a physician for immediate management. After care was initiated in triage, ED physicians assessed all children according to usual ED protocol. At that time, the physician assessed the success of the oral rehydration attempt and considered the child's ability to initiate a regular diet.
Data Collection
For patients treated under the triage protocol, the triage nurse and treating physician collected data on standardized case report forms. Data elements collected included the degree of dehydration at triage (Table 1) , antiemetic medication dosing and administration, documentation of the provision of oral rehydration when indicated, and the use of IV fluid administration. Research assistants abstracted additional data on demographics and ED course, including the use of diagnostic studies (including blood testing, urine testing, and imaging studies), and ED disposition (discharge or hospital admission) from the electronic health record (EHR). Families were contacted 1 week after ED discharge to determine if the patient required unscheduled follow-up care for vomiting or diarrhea at an ED, urgent care, or clinic.
Comparable data on control subjects were collected retrospectively through research assistant review of standard documentation present in the EHR. This included review of nursing and physician documentation of fluids offered and consumed by patients during their ED stays. Dehydration score information was not available on control subjects, as staff had not been trained on score calculation prior to the initiation of the intervention.
Data Analysis and Outcomes
The primary outcomes were the use ORT, use of antiemetics, and administration of IV fluids. Admission rate, unscheduled return visits for persistent symptoms, laboratory testing, and ED length of stay were measured as secondary outcomes. The differences between preprotocol and postprotocol results were tested with a t test with unequal variances for continuous outcomes and Fisher exact test for categorical outcomes. The difference between dehydration scores by the triage nurse and the physician was tested with a paired t test. All data management and analysis were done in SAS (version 9.3; The SAS Institute, Cary, NC).
Sample Size
Based on a review of our preimplementation practice, we estimated that less than 10% of patients were offered oral rehydration but that 50% of children in our ED were no more than mildly dehydrated. We conservatively estimated that we would be able to increase our rate of ORT from 10% to 30%. In order to have 80% power to detect a 20% change in use of oral rehydration with a false-positive rate of 5% (ie, α), we needed to enroll 100 children with dehydration (50 patients before and 50 patients after implementation).
RESULTS
A total of 128 patients were enrolled into the study. Eightyone children were enrolled between November 8, 2011, and April 30, 2012. Forty-seven preintervention control subjects were identified by review of medical records of patients seen in the ED during the 4 months prior to implementation of the protocol. Table 2 presents patient demographics and presenting complaint information. A high proportion of patients required language interpreters for their care, most commonly Somali (15% of all patients) or Spanish (4%). Although report of diarrhea to the nurse at the time of triage was a requirement for inclusion in the study, diarrhea was not listed as a chief complaint in all patients. There were significant differences in the proportion of patients before and after intervention reporting abdominal pain and vomiting as chief complaints. The difference in abdominal pain is likely due to the postintervention screening out of patients with significant abdominal pain from care under the study protocol; the difference in vomiting is likely due to the fact that the study protocol specifically prompted triage nurses to screen for and document vomiting.
Although preintervention control charts were reviewed for documentation of dehydration, it was found that triage nurses documented consideration of dehydration in only 9% of cases Percentages add up to more than 100 because some patients had multiple chief complaints. ‡ Measures inclusion of diarrhea among patient's reported chief complaints; report of diarrhea at the time of triage was a requirement for study inclusion.
during the preintervention period; all of these were described as having no dehydration. Physicians included at least some documentation regarding dehydration in 85% of preintervention cases; 78% of these were described as having no dehydration. Table 3 presents the documented degree of dehydration in postintervention patients. The mean dehydration score calculated by the triage nurse in postintervention cases was 1.06 (SD, 1.31). The mean dehydration score calculated by physicians at the time of their assessment was 0.99 (SD, 1.23); P value for this difference in a paired comparison was 0.65.
Although the study protocol called for an unstructured oral challenge for patients with dehydration scores of 0 (later amended to 0 or 1) and structured oral rehydration for scores of 1 to 4 (amended to 2-4), in practice, documentation of adherence to formal rehydration versus unstructured oral challenge was poor. Type of fluid given was documented in less than half of postintervention cases; 27% received juice, 19% received Pedialyte, 17% received Gatorade, 17% received an ice pop, and the remaining patients received other fluids. Table 4 outlines the clinical findings and outcomes. Significant differences were found in a number of aspects of patient care before and after initiation of the triage-based protocol. The documentation of ORT was significantly different preintervention and postintervention (P < 0.001). In addition, there were significant differences in ondansetron use (P < 0.001), time to ondansetron (P = 0.004), and IVF use (P = 0.03). This difference was persistent when patients with documented vomiting were considered separately as well and thus was not attributable to the difference in the proportion of patients in the 2 groups with vomiting. There was no significant difference in the probability of obtaining any laboratory studies between the 2 groups, but there was a significant difference in the proportion of patients having blood tests. No significant differences were found in admission rate, ED length of stay, or rate of unscheduled return to care for symptoms of gastroenteritis.
At the time of discharge from the ED, 17% of preimplementation patients and 52% of postimplementation patients were discharged with prescriptions for ondansetron (P < 0.001).
DISCUSSION
We have demonstrated that a triage nurse-based protocol for early assessment of dehydration in children with gastroenteritis can significantly increase the early use of ondansetron and the initiation of ORT. The result is a significant decrease in the use of IVFs and blood testing, without increase in the length of the ED visit, rate of admission to the hospital, or unscheduled return to medical care after discharge. These findings lend support to the safety and efficacy of nurse-initiated use of ondansetron and oral rehydration in children with symptoms of gastroenteritis. Previous studies have shown improvements in timing and delivery of pain medication with triage-based nursing protocols, 13, 14 supporting the idea that nurse-initiated delivery of medications at the time of triage can be a helpful adjunct to standard ED care. In addition, prior investigations have demonstrated successful early initiation of oral rehydration in the pediatric ED. [18] [19] [20] However, to our knowledge, none have assessed the use of ondansetron at the time of triage to support oral rehydration. The efficacy of triage nurseinitiated provision of ondansetron in limiting the use of IV rehydration and blood testing in children with vomiting presumed to be due to gastroenteritis is a key finding of this study.
Previous assessments of agreement between triage nurse and physician interpretation of patient findings have shown mixed [23] [24] [25] However, independent patient assessment by triage nurses is clearly an important part of ED practice. In the validation study for the dehydration scale from which ours is adapted, the triage nurse assessment of dehydration score was used as the primary assessment for the study. 22 In this investigation, we found that triage nurses and treating physicians showed similar calculation of dehydration scores, with a marked increase in nurses documenting the degree of dehydration. These findings further support the feasibility of involving triage nurses in the assessment of degree of dehydration.
The initial protocol for this study was designed to mimic formal oral rehydration approaches described in the literature, 4 with frequent, small doses of rehydration solution for patients who had any clinical dehydration. However, we found this approach to be poorly tolerated in our patient population. In patients with mild dehydration, the WHO ORS was not considered palatable, and families preferred to offer unrestricted oral fluid. This low tolerance of formal rehydration is likely attributable to the effects of ondansetron, which decreased ongoing vomiting and obviated the use of small, timed quantities of oral fluid. Despite the use of a less formal approach to oral rehydration, the 2.5% rate of hospital admission in this study was lower than the 11% reported with the use of formal rehydration without antiemetics by Atherly-John et al. 4 That study reported no patients requiring unscheduled return to care on 2-to 4-day follow-up, in contrast to our rates of 15% before and 19% after intervention. However, the difference in admission rates and the fact that our follow-up calls were made at least 1 week after the ED visit render these results difficult to compare. The rates of unscheduled return to care in this study were comparable to those reported in the initial study by Freedman et al 10 assessing the use of oral ondansetron in children with gastroenteritis in the ED.
The initial studies supporting the use of ondansetron in pediatric gastroenteritis patients describe the use of a single dose in the ED; they make no comment on its prescription at the time of discharge. 10, 11 An older investigation reported that 9% of children seen for acute gastroenteritis filled prescriptions for antiemetics, but 92% of these were for promethazine. 26 In our sample, while the protocol did not specifically promote the prescription of ondansetron for home use in discharged patients, 52% of patients in the postintervention period of this study were discharged with a prescription for ondansetron. Despite the clinical plausibility of ED discharge prescription of ondansetron as a safe and useful intervention for children with ongoing vomiting in the setting of gastroenteritis, we are not aware of literature specifically supporting or refuting this approach. Further study of the role of home use of ondansetron in gastroenteritis would be helpful to guide ongoing practice.
LIMITATIONS
This study was limited by the necessity of retrospective data collection for the preintervention period and by the inability to formulate exact comparisons between the routine EHR documentation available prior to the intervention and the prospectively collected postintervention data. For example, the proportion of control subjects with vomiting, as a potential indication for ondansetron use, was gathered based on report of vomiting as part of the chief complaint at triage. This almost certainly understated the number of control subjects with vomiting, as triage nurses in the preintervention period were not prompted to seek this history. However, a larger denominator of preintervention patients with vomiting would tend to render the differences in ondansetron use after protocol implementation more striking rather than less. Likewise, the necessarily different approach to identifying patients before and after intervention led to a discrepancy in the number of patients with abdominal pain included among their chief complaints. This could potentially have introduced bias in either direction. However, the total number of patients affected by this difference was small: 5 before and 1 after intervention.
In addition, the use of a contiguous time period for the control group may have had an unknown effect on the data given the seasonal variation in pediatric gastroenteritis, although we expect that the effect this would have on the treatment given to patients presenting with similar symptoms would be small.
Eligible patients were likely missed during the postintervention period because of paper-based, rather than electronic, data collection, and as with all studies of this type, there is the possibility that nurse and physician behavior in the postintervention period was influenced in unmeasured ways by the awareness that the study was underway. Last, the generalizability of these findings may be limited by the study's conduction in a single, urban, tertiary-care hospital ED.
CONCLUSIONS
A nurse-initiated, triage-based protocol for early initiation of oral ondansetron and ORT in children with evidence of gastroenteritis is associated with increased and earlier use of ondansetron and ORT and decreased use of IV fluids and blood testing without lengthening ED stays or increasing rates of admission or unscheduled return to care.
